Search Results for: Geron

Hateful politics infiltrate human genome editing debate in France

/ / 1 Comment
Stop-Baby-GMO-Campaign-e1466871220436

By Elliot Hosman Summary.  A campaign calling for a moratorium on using CRISPR in human embryos was launched by a prominent French organization fighting for narrow understandings of life and family. A recent campaign calling for a ban on “transgenic” human embryos was launched by one of France’s most prominent organizations fighting for “science”-backed “one-man-one-woman” […]

Hateful politics infiltrate human genome editing debate in France Read More »

Stem Cell Person of the Year 2014 Award: Vote To Choose 12 Finalists

/ / 4 Comments
Stem-Cell-Symbol

Nominations have closed and we have more than two dozen nominations for Stem Cell Person of the Year 2014. It’s an exciting, diverse group including some news faces as well as nominees from years past as well. Happy Stem Cell Day! You can now vote for your choice for the top finalists in the poll

Stem Cell Person of the Year 2014 Award: Vote To Choose 12 Finalists Read More »

BioTime Cell Cure Files IND with FDA for ES cell AMD therapy

/ / 2 Comments
Cell-Cure-Logo

Stem cell biotech BioTime announced the news today that its subsidiary Cell Cure Neurosciences (Cell Cure) has filed an IND with the FDA for an embryonic stem (ES) cell-based therapy for Dry age-related macular degeneration (AMD). The product to be tested is OpRegen, which the company indicates is “the first IND for an ES cell-based

BioTime Cell Cure Files IND with FDA for ES cell AMD therapy Read More »

Interview with Jane Lebkowski on Asterias FDA-approved Stem Cell Trial

/ / 1 Comment
jane-lebkowski, Asterias

The BioTime subsidiary, Asterias, has received FDA approval for a combined Phase I/IIa clinical trial of OPC1 for treating spinal cord injury. BioTime (BTX) and Asterias (ASTY) have picked up the portfolio of the former Geron clinical trial using oligodendrocyte precursor cells (OPC). Asterias also acquired a second element from Geron in the form of a lung

Interview with Jane Lebkowski on Asterias FDA-approved Stem Cell Trial Read More »

Great News: FDA Nod For ViaCyte IND of Diabetes Stem Cell-Based Product

/ / 8 Comments
ViaCyte-logo-3x2

Type 1 Diabetes is a huge global problem. Where are the solutions that would compliment or replace insulin therapy for diabetics? There haven’t been too many that have gotten very far, which makes the news of a potential stem cell-based therapy moving along in the pipeline all the more exciting. ViaCyte (see more posts here,

Great News: FDA Nod For ViaCyte IND of Diabetes Stem Cell-Based Product Read More »

TGIF stem cell headlines of week: Asterias, lasers, immunity, & more

/
Laser-tooth-stem-cells

It’s been an important week for stem cells. Although I’ve been busy working on multiple grants and papers, when I take a break I like to read up on what’s been going on with stem cells. What are the top stem cell stories and headlines of the week? CIRM awarded Asterias (a subsidiary of BioTime)

TGIF stem cell headlines of week: Asterias, lasers, immunity, & more Read More »

Has anti-aging finally come of age with Google’s Calico?

/ / 3 Comments

Can Google’s new anti-aging company, Calico, have you Googling at age 140? Don’t sell your burial plot just yet. The idea of anti-aging has been around for a very long time and efforts to combat aging have spanned millennia largely without any success so Calico (apparently short for California Life Company, which sounds more like

Has anti-aging finally come of age with Google’s Calico? Read More »